Back to the main directory
EarningsReview / Equity
- Itaú BBA on Hypera: Widely Anticipated, In Line Results by Itau
- Prestige Estates Projects (PEPL IN) by HSBC
- Itaú BBA on CBA: Miss On Costs; Maintenance Works Took A Toll by Itau
- Itaú BBA on Suzano: Slight Beat; Capex Guidance Revised Upwards by Itau
- Trent (TRENT IN) by HSBC
- Marginal producer Liontown Resource seeks equity raising, mildly negative for lithium names by BNP Paribas Exane
- Growth, growth… but what about FCF growth by BNP Paribas Exane
- Growth capex, dividends, net debt target - one’s got to go by BNP Paribas Exane
- 100% Tariffs On Semiconductors: Bark, No Bite? by BNP Paribas Exane
- Factory reset by BNP Paribas Exane
- FQ2’25 postview: Successfully navigating trade disruption by BNP Paribas Exane
- Weak FY guide masks growth opportunity: Keep the Faith by BNP Paribas Exane
- After the call: wait, was that a guidance upgrade? by BNP Paribas Exane
- EUR10.6bn Messina bridge signed but more positives may come in our view by BNP Paribas Exane
- Novo Nordisk - Trimming the fat from estimates by Danske Bank Equity Research
- Sampo - A good quarter by Danske Bank Equity Research
- Q2 results: P&C attritional lead the way by BNP Paribas Exane
- Q2 miss but guidance changes leave consensus unchanged by BNP Paribas Exane
- Buzzi - EYES ON US RECOVERY AND STRENGTHENING EUROPE by Equita Sim
- Q3’25 results - mixed - as expected, but probably enough by BNP Paribas Exane
- H125 results: probably good enough by BNP Paribas Exane
- 1QFY26 first take: Revenue missed but margin beat on aggressive cost cuts by BNP Paribas Exane
- 2Q25 Results: Mixed Swiss trends, Italian EBITDA beat and guidance reiterated by BNP Paribas Exane
- Q225 results - First Response by BNP Paribas Exane
- H125 results a small EBIT beat on margins / ancillaries, but RevPAR trends no weaker than flagged by US peers, could be positive today by BNP Paribas Exane